David Sinclair: AI Might Solve Longevity, GLP-1 Side Effects, and Longevity Investing | MOONSHOTS

During the AMA at Abundance Summit, David Sinclair got asked some of the biggest questions in longevity: his answers were fascinating.

– GLP-1s may benefit the heart and brain beyond weight loss, but he flagged rare blindness risks we need to understand

– AI is helping screen billions, and eventually trillions, of molecules for age-reversal compounds

– At least half of your lifespan may still be up to you, even if longevity runs in your family

– OSK / ER100 therapy is showing early animal data in ALS, glaucoma, and macular degeneration models

– The indoor environment matters more than most people think: air, water, plastics, Teflon, mold, and light